Qube Research & Technologies (QRT)
CLX icon

Qube Research & Technologies (QRT)’s Clorox CLX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-458,337
Closed -$52M – 3598
2025
Q4 		$46.2M Sell
458,337
-636,232
-58% -$69.1M 0.05% 529
2025
Q3 		$135M Sell
1,094,569
-1,263,303
-54% -$157M 0.14% 173
2025
Q2 		$283M Buy
2,357,872
+1,684,594
+250% +$225M 0.29% 65
2025
Q1 		$99.1M Buy
673,278
+302,210
+81% +$46.1M 0.12% 222
2024
Q4 		$60.3M Buy
371,068
+117,229
+46% +$19.2M 0.08% 323
2024
Q3 		$41.4M Sell
253,839
-55,434
-18% -$8.21M 0.06% 401
2024
Q2 		$42.2M Buy
309,273
+190,875
+161% +$26.5M 0.07% 343
2024
Q1 		$18.1M Sell
118,398
-83,623
-41% -$12.5M 0.03% 606
2023
Q4 		$28.8M Sell
202,021
-928,460
-82% -$124M 0.06% 411
2023
Q3 		$148M Buy
1,130,481
+487,974
+76% +$74.2M 0.39% 45
2023
Q2 		$102M Buy
642,507
+450,387
+234% +$72.6M 0.37% 67
2023
Q1 		$30.4M Sell
192,120
-118,034
-38% -$17.7M 0.13% 173
2022
Q4 		$43.5M Buy
+310,154
New +$44M 0.23% 100
2022
Q1 		– Sell
-56,852
Closed -$9.91M – 2504
2021
Q4 		$9.91M Buy
+56,852
New +$9.48M 0.08% 348
2021
Q2 		– Sell
-4,363
Closed -$842K – 2327
2021
Q1 		$842K Sell
4,363
-11,641
-73% -$2.24M 0.01% 916
2020
Q4 		$3.23M Sell
16,004
-40,123
-71% -$8.3M 0.05% 444
2020
Q3 		$11.8M Buy
+56,127
New +$12.5M 0.17% 135
2019
Q2 		– Sell
-7,268
Closed -$1.17M – 421
2019
Q1 		$1.17M Buy
7,268
+5,582
+331% +$866K 0.15% 178
2018
Q4 		$260K Sell
1,686
-773
-31% -$120K 0.11% 220
2018
Q3 		$370K Buy
+2,459
New +$349K 0.05% 291

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CLX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Clorox (CLX) in Q1 2026, closing a stake of 458,337 shares — an estimated $52M sold.

Qube Research & Technologies (QRT) first reported a position in CLX in Q3 2018 and held it in 20 quarters. The position peaked at $283M in Q2 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 458,337 Clorox shares in Q1 2026, an estimated $52M.
  • Qube Research & Technologies (QRT) first reported a position in Clorox in Q3 2018 and held it in 20 quarters.
  • Qube Research & Technologies (QRT)'s Clorox position peaked at $283M in Q2 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.